Aktienanalyse wird geladen …
MTD · NYSE · Diagnostics & Research · Schweiz
1.517,79 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 4,03 Mrd. | 869,19 Mio. | 42,05 $ | 20,67 Mio. | 0 Mio · 0,1 % | 0,7 Mio · 3,2 % | 59,4 % | 21,6 % | 41,05 $ | 1,09 $ | — |
| 2024 | 3,87 Mrd. | 863,14 Mio. | 40,48 $ | 21,32 Mio. | 0 Mio · 0,1 % | 0,7 Mio · 3,1 % | 60,1 % | 22,3 % | 40,55 $ | 0,94 $ | — |
| 2023 | 3,79 Mrd. | 788,78 Mio. | 35,90 $ | 21,97 Mio. | 0 Mio · 0,1 % | 0,8 Mio · 3,5 % | 59,2 % | 20,8 % | 39,17 $ | 0,82 $ | — |
| 2022 | 3,92 Mrd. | 872,5 Mio. | 38,41 $ | 22,72 Mio. | 0 Mio · 0,1 % | 0,8 Mio · 3,3 % | 58,9 % | 22,3 % | 32,48 $ | 0,87 $ | — |
| 2021 | 3,72 Mrd. | 768,99 Mio. | 32,78 $ | 23,46 Mio. | 0 Mio · 0,1 % | 0,8 Mio · 3,2 % | 58,4 % | 20,7 % | 34,16 $ | 0,84 $ | — |
| 2020 | 3,09 Mrd. | 602,74 Mio. | 24,91 $ | 24,2 Mio. | 0 Mio · 0,1 % | 0,8 Mio · 3,3 % | 58,4 % | 19,5 % | 26,13 $ | 0,77 $ | — |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,03 Mrd. | 232,9 Mio. | 11,55 $ | 20,17 Mio. | 63,3 % | 22,7 % | 14,01 $ |
| Q1 2026 | 947,13 Mio. | 169,45 Mio. | 8,33 $ | 20,34 Mio. | 58,7 % | 17,9 % | 6,02 $ |
| Q4 2025 | 1,13 Mrd. | 285,77 Mio. | 13,82 $ | 20,44 Mio. | 59,8 % | 25,3 % | 8,90 $ |
| Q3 2025 | 1,03 Mrd. | 217,49 Mio. | 10,57 $ | 20,57 Mio. | 59,2 % | 21,1 % | 13,36 $ |
| Q2 2025 | 983,22 Mio. | 202,35 Mio. | 9,76 $ | 20,74 Mio. | 59 % | 20,6 % | 10,25 $ |
| Q1 2025 | 883,74 Mio. | 163,59 Mio. | 7,81 $ | 20,95 Mio. | 59,5 % | 18,5 % | 8,46 $ |
| Q4 2024 | 1,05 Mrd. | 252,3 Mio. | 12,21 $ | — | 61,2 % | 24,1 % | 10,88 $ |
| Q3 2024 | 954,54 Mio. | 211,52 Mio. | 9,96 $ | 21,24 Mio. | 60 % | 22,2 % | 10,98 $ |
Goldman Sachs Adjusts PT on Mettler-Toledo International to $1,510 From $1,440, Keeps Neutral Rating
What Makes Mettler-Toledo International (MTD) an Attractive Bet?
Is Mettler-Toledo Stock Underperforming the Nasdaq?
Research Tools & Consumables Stocks Q2 Teardown: Mettler-Toledo (NYSE:MTD) Vs The Rest
Mettler-Toledo International Shares Fall After UBS Downgrade
UBS Downgrades Mettler-Toledo International to Neutral From Buy, Adjusts Price Target to $1,460 From $1,650
Mettler-Toledo International Inc. is a global precision instruments company that provides weighing, analytical, and inspection solutions for laboratory, industrial, and food retail customers. Its product portfolio includes laboratory balances, pipettes, pH meters, process analytics instruments, metal detection systems, and end-of-line inspection equipment used in research, quality control, production, logistics, and retail operations. The company serves industries such as life sciences, pharmaceuticals, biotechnology, chemicals, manufacturing, and food processing, where measurement accuracy and process reliability are essential. Mettler-Toledo International Inc. also supports customers with related services and a worldwide sales and service network, making it an important supplier of mission-critical measurement technologies across multiple regulated and production-intensive markets.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest MTD und jede andere Aktie unbegrenzt.